CN102197014B — γ,δ-不饱和酮类的制备
Assigned to DSM IP Assets BV · Expires 2013-12-04 · 12y expired
What this patent protects
一种用于制备通式为(R 1 )(R 2 )C=CH-CH 2 -CH 2 -CO-R 3 (I)的γ,δ-不饱和酮的方法,其中R 1 是甲基或乙基;R 2 是饱和的或不饱和的线性或环状烃类残基;R 3 是甲基或乙基,所述方法包括,在作为催化剂的铵盐的存在下,使式(R 1 )(R 2 )C(OH)-CH=CH 2 (II)的叔乙烯基甲醇与式H 3 C-C(OR 3 )=CH 2 (III)的异丙烯基甲基醚或异丙烯基乙基醚反应。
USPTO Abstract
一种用于制备通式为(R 1 )(R 2 )C=CH-CH 2 -CH 2 -CO-R 3 (I)的γ,δ-不饱和酮的方法,其中R 1 是甲基或乙基;R 2 是饱和的或不饱和的线性或环状烃类残基;R 3 是甲基或乙基,所述方法包括,在作为催化剂的铵盐的存在下,使式(R 1 )(R 2 )C(OH)-CH=CH 2 (II)的叔乙烯基甲醇与式H 3 C-C(OR 3 )=CH 2 (III)的异丙烯基甲基醚或异丙烯基乙基醚反应。
Drugs covered by this patent
- Antizol (FOMEPIZOLE) · Par Pharm Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.